Author

A. E. Tseng

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

D. N. Kotton· 2 shared H. P. Gertje· 2 shared N. A. Crossland· 2 shared A. A. Wilson· 1 shared A. B. Balazs· 1 shared A. Belkina· 1 shared A. Cupic· 1 shared A. D. Nitido· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. N. Kotton

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues

D. J. Kenney, A. K. O'Connell, A. E. Tseng, J. Turcinovic, M. L. Sheahan, A. D. Nitido, P. Montanaro, H. P. Gertje, M. Ericsson, J. H. Connor, V. Vrbanac, N. A. Crossland, C. Harly, A. B. Balazs, F. Douam

This study identifies immune signatures associated with SARS-CoV-2 infection resolution in human lung tissues using a humanized mouse model.

bioRxiv · Mar 8, 2024Immunology

Aberrant macrophage activation and maladaptive lung repair promote tuberculosis progression uniquely in the lung

S. M. Yabaji, S. Lata, A. E. Tseng, P. B. Araveti, M. Lo, I. Gavrish, A. K. O'Connel, H. P. Gertje, A. Belkina, C. E. Thurman, H. Kiyokawa, D. N. Kotton, S. Tan, J. J. Endsley, W. R. Bishai, , I. Kramnik

This study identifies aberrant macrophage activation and maladaptive lung repair as key factors promoting tuberculosis progression in the lung using a novel mouse model.

bioRxiv · Oct 17, 2023 · PreprintImmunology

The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters

L. Miorin, C. E. Mire, S. Ranjbar, A. J. Hume, J. Huang, N. A. Crossland, K. M. White, M. Laporte, T. Kehrer, V. Haridas, E. Moreno, A. Nambu, S. Jangra, A. Cupic, M. Dejosez, , A. E. Goldfeld

The paper shows that nitazoxanide inhibits SARS-CoV-2 replication and pathogenesis in human and hamster models, and synergizes with remdesivir against multiple variants.

bioRxiv · Feb 8, 2022 · PreprintImmunology